Stockreport

OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights

ONCOMED PHARMACEUTICALS  (OMED) 
Last oncomed pharmaceuticals earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: oncomed.com/invest/index.cfm
PDF -Company prioritizes its navicixizumab resources in platinum-resistant ovarian cancer; prepares to share data in Q4 of 2018- -Cash runway extended by an additional quar [Read more]